Endometriosis is a disease where tissue similar to the lining of the uterus grows outside the uterus, causing pain and/or infertility. It affects approximately 1 in 10 females (and people assigned female at birth) - approximately 190 million people.

More specifically, people with endometriosis can have: painful periods, pelvic pain, pain related to sex, pain with bowel movements, pain during urination, fatigue, depression, anxiety, bloating, nausea, and/or infertility.

In females, gynecologic conditions like endometriosis, uterine fibroids, polycystic ovary syndrome, premature ovarian insufficiency, or endometrial polyps can cause infertility.

The causes of endometriosis are unclear. The three main explanations are thought to include: retrograde (‘backward’) menstruation, cellular metaplasia (‘changes’), and stem cells giving rise to the disease. Learn more from AIMA Labs.

Using a small blood sample, this test identifies certain microRNA biomarkers that are differentially expressed in women with endometriosis compared to women without. The test’s accuracy is comparable to laparoscopy, a type of surgery that is used to get a closer look into a woman’s abdomen and reproductive system.

​

This test will complement laparoscopic procedures. The test is a noninvasive way to test for endometriosis and diagnose endometriosis sooner. Which will allow patients who receive a positive test result to undergo a laparoscopy for treatment potentially years sooner than they would otherwise.

We've partnered with AIMA Labs to create this test. AIMA Laboratories Inc. is a Canadian, pre-clinical FemTech company co-founded by two scientists who have dedicated their professional lives to researching reproductive endocrinology and infertility.

​

Innovative Health Diagnostics (IHD Lab) together with AIMA Labs is working to empower every person by providing access to accurate, clinical testing, when and where it matters most.